Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Houston researchers test lung inhalant that could protect healthcare workers from COVID-19

Posted on March 30, 2020March 30, 2020 by Brenton Scott
Posted in News Coverage

Post navigation

Pulmotect’s PUL-042 Shows Promising Pre-Clinical Efficacy in Preventing Lethal Coronavirus Infection
Houston biotech co.’s coronavirus treatment candidate to undergo clinical trials
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2025
Pulmotect, Inc.